Search by Drug Name or NDC
NDC 00169-4181-97 Ozempic 0.68 mg/mL Details
Ozempic 0.68 mg/mL
Ozempic is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SEMAGLUTIDE.
Product Information
| NDC | 00169-4181 |
|---|---|
| Product ID | 0169-4181_7f4b992f-d010-4e6a-a475-d7133df0ebff |
| Associated GPIs | |
| GCN Sequence Number | 084300 |
| GCN Sequence Number Description | semaglutide PEN INJCTR .25 OR 0.5 SUBCUT |
| HIC3 | C4I |
| HIC3 Description | ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST) |
| GCN | 53536 |
| HICL Sequence Number | 044675 |
| HICL Sequence Number Description | SEMAGLUTIDE |
| Brand/Generic | Brand |
| Proprietary Name | Ozempic |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | semaglutide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 0.68 |
| Active Ingredient Units | mg/mL |
| Substance Name | SEMAGLUTIDE |
| Labeler Name | Novo Nordisk |
| Pharmaceutical Class | GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209637 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00169-4181-97 (00169418197)
| NDC Package Code | 0169-4181-97 |
|---|---|
| Billing NDC | 00169418197 |
| Package | 1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-90) |
| Marketing Start Date | 2022-10-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |